DNA Script

Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis

Biotechnology 📍 Paris, France Founded 2014

Current Valuation

$677.15M

as of 2021-Q4

PRIVATE

Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis

Company Profile

Founded

2014

Paris, France

Employees

132

Total Raised

$298.87M

Last Round

Series C — $196.71M (Oct 2021)

IPO Status

private

Fundraising Status

Series C · $196.71M · 4y 10mo ago

privateTotal raised $298.87M

Latest Funding Round

Round	Amount	Date	Lead Investor	Post-Money
Series C	$196.71M	Oct 2021	—	$677.15M

MedicalHealth CareBiotechnologyLife Science

Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.